These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7679949)

  • 1. Hyperphosphorylation of cytokeratins by okadaic acid class tumor promoters in primary human keratinocytes.
    Yatsunami J; Komori A; Ohta T; Suganuma M; Yuspa SH; Fujiki H
    Cancer Res; 1993 Mar; 53(5):992-6. PubMed ID: 7679949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperphosphorylation of retinoblastoma protein and p53 by okadaic acid, a tumor promoter.
    Yatsunami J; Komori A; Ohta T; Suganuma M; Fujiki H
    Cancer Res; 1993 Jan; 53(2):239-41. PubMed ID: 8417815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of synergistic effects on tumor promotion in CD-1 mouse skin by simultaneous applications of two different types of tumor promoters, okadaic acid and teleocidin.
    Suganuma M; Yatsunami J; Yoshizawa S; Okabe S; Fujiki H
    Cancer Res; 1993 Mar; 53(5):1012-6. PubMed ID: 8439947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of action of okadaic acid class tumor promoters on mouse skin.
    Fujiki H; Suganuma M; Yoshizawa S; Nishiwaki S; Winyar B; Sugimura T
    Environ Health Perspect; 1991 Jun; 93():211-4. PubMed ID: 1663450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible hyperphosphorylation and reorganization of vimentin intermediate filaments by okadaic acid in 9L rat brain tumor cells.
    Lee WC; Yu JS; Yang SD; Lai YK
    J Cell Biochem; 1992 Aug; 49(4):378-93. PubMed ID: 1331124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the cytokeratin cytoskeleton and inhibition of hepatocytic autophagy by okadaic acid.
    Blankson H; Holen I; Seglen PO
    Exp Cell Res; 1995 Jun; 218(2):522-30. PubMed ID: 7540986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin.
    Suganuma M; Fujiki H; Furuya-Suguri H; Yoshizawa S; Yasumoto S; Kato Y; Fusetani N; Sugimura T
    Cancer Res; 1990 Jun; 50(12):3521-5. PubMed ID: 2160320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperphosphorylation of keratins by treatment with okadaic acid of BALB/MK-2 mouse keratinocytes.
    Kasahara K; Kartasova T; Ren XQ; Ikuta T; Chida K; Kuroki T
    J Biol Chem; 1993 Nov; 268(31):23531-7. PubMed ID: 7693689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Okadaic acid Co-induces vimentin expression and cell cycle arrest in MPC-11 mouse plasmacytoma cells.
    Giese G; Wiegers W; Kubbies M; Scherbarth A; Traub P
    J Cell Physiol; 1995 Apr; 163(1):145-54. PubMed ID: 7896891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of phosphorylation on the antigenic reactivity of p53 in cultured human keratinocytes.
    Kumar M; Spandau DF
    Biochem Biophys Res Commun; 1995 Sep; 214(2):744-53. PubMed ID: 7545906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vimentin is hyperphosphorylated in primary human fibroblasts treated with okadaic acid.
    Yatsunami J; Fujiki H; Suganuma M; Yoshizawa S; Eriksson JE; Olson MO; Goldman RD
    Biochem Biophys Res Commun; 1991 Jun; 177(3):1165-70. PubMed ID: 1647766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vimentin serves as a phosphate sink during the apparent activation of protein kinases by okadaic acid in mammalian cells.
    Lai YK; Lee WC; Chen KD
    J Cell Biochem; 1993 Oct; 53(2):161-8. PubMed ID: 7693732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperphosphorylation of p53 induced by okadaic acid attenuates its transcriptional activation function.
    Zhang W; McClain C; Gau JP; Guo XY; Deisseroth AB
    Cancer Res; 1994 Aug; 54(16):4448-53. PubMed ID: 8044794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach.
    Suganuma M; Okabe S; Sueoka E; Nishiwaki R; Komori A; Uda N; Isono K; Fujiki H
    J Cancer Res Clin Oncol; 1995; 121(9-10):621-7. PubMed ID: 7559747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of protein phosphatases 1 and 2A in collagen-platelet interaction.
    Chiang TM
    Arch Biochem Biophys; 1993 Apr; 302(1):56-63. PubMed ID: 8385905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice.
    Xian W; Kiguchi K; Imamoto A; Rupp T; Zilberstein A; DiGiovanni J
    Cell Growth Differ; 1995 Nov; 6(11):1447-55. PubMed ID: 8562483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperphosphorylation of cytokeratins 8 and 18 by microcystin-LR, a new liver tumor promoter, in primary cultured rat hepatocytes.
    Ohta T; Nishiwaki R; Yatsunami J; Komori A; Suganuma M; Fujiki H
    Carcinogenesis; 1992 Dec; 13(12):2443-7. PubMed ID: 1282096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of protein phosphatase 2A with its substrate vimentin intermediate filaments in 9L rat brain tumor cells.
    Cheng TJ; Lin YL; Chiang AS; Lai YK
    J Cell Biochem; 2000 Jul; 79(1):126-38. PubMed ID: 10906761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of mallory body formation induced by okadaic acid in drug-primed mice.
    Yuan QX; Nagao Y; Gaal K; Hu B; French SW
    Exp Mol Pathol; 1998 Oct; 65(2):87-103. PubMed ID: 9828150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Okadaic acid as an inducer of the 78-kDa glucose-regulated protein in 9L rat brain tumor cells.
    Hou MC; Shen CH; Lee WC; Lai YK
    J Cell Biochem; 1993 Jan; 51(1):91-101. PubMed ID: 8381791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.